Literature DB >> 7707085

Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction.

Y W Chia1, C J Fowler, M A Kamm, M M Henry, M C Lemieux, M Swash.   

Abstract

Urinary dysfunction is common in cases of multiple sclerosis (MS). The close proximity of those neural pathways which control the bladder to those which control anorectal function might be expected to lead to a high coexistence of bladder and bowel symptoms. Seventy-seven consecutive patients with clinically definite MS attending a uroneurology clinic were interviewed about their bowel function. All patients had clinical evidence of spinal cord disease with varying degrees of impaired mobility and sufficiently severe disturbance of bladder control to seek medical advice. Thirty-six per cent of these patients had constipation. Twenty per cent had "current incontinence", although another 30% had had at least one episode of faecal incontinence more than 3 months previously. Some patients had both constipation and faecal incontinence. A total of 52% currently had at least one bowel symptom. The pattern of bowel symptoms did not correlate with the pattern of urinary disturbance, or the duration of MS, or the degree of disability. Bowel symptoms are common in patients with MS, but even in those with urinary dysfunction are not universal. Whereas bladder dysfunction in MS is clearly related to spinal cord disease, the neurological basis for the bowel dysfunction is less clear.

Entities:  

Mesh:

Year:  1995        PMID: 7707085     DOI: 10.1007/bf00887825

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Spinal pathways subserving defaecation and sensation from the lower bowel.

Authors:  P W NATHAN; M C SMITH
Journal:  J Neurol Neurosurg Psychiatry       Date:  1953-11       Impact factor: 10.154

2.  Behavioral modification of colonic function. Can constipation be learned?

Authors:  A G Klauser; W A Voderholzer; C A Heinrich; N E Schindlbeck; S A Müller-Lissner
Journal:  Dig Dis Sci       Date:  1990-10       Impact factor: 3.199

3.  Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters.

Authors:  K W Heaton; L J O'Donnell; F E Braddon; R A Mountford; A O Hughes; P J Cripps
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

4.  Innervation of the detrusor muscle and urethra.

Authors:  W E Bradley; G W Timm; F B Scott
Journal:  Urol Clin North Am       Date:  1974-02       Impact factor: 2.241

5.  Gastrointestinal dysfunction in multiple sclerosis.

Authors:  S N Sullivan; G C Ebers
Journal:  Gastroenterology       Date:  1983-06       Impact factor: 22.682

6.  Traumatic constipation.

Authors:  G Devroede; P Arhan; C Duguay; L Tétreault; H Akoury; B Perey
Journal:  Gastroenterology       Date:  1979-12       Impact factor: 22.682

7.  Epidemiology of colonic symptoms and the irritable bowel syndrome.

Authors:  N J Talley; A R Zinsmeister; C Van Dyke; L J Melton
Journal:  Gastroenterology       Date:  1991-10       Impact factor: 22.682

8.  Gastrointestinal complications of spinal cord injury.

Authors:  R M Gore; R A Mintzer; L Calenoff
Journal:  Spine (Phila Pa 1976)       Date:  1981 Nov-Dec       Impact factor: 3.468

9.  Irritable bowel syndrome in the general population.

Authors:  R Jones; S Lydeard
Journal:  BMJ       Date:  1992-01-11

Review 10.  Colonic and anorectal dysfunction associated with multiple sclerosis.

Authors:  J P Hinds; A Wald
Journal:  Am J Gastroenterol       Date:  1989-06       Impact factor: 10.864

View more
  23 in total

Review 1.  Constipation in neurological diseases.

Authors:  K Winge; D Rasmussen; L M Werdelin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  Metaboreflex activity in multiple sclerosis patients.

Authors:  Elisabetta Marongiu; Sergio Olla; Sara Magnani; Girolamo Palazzolo; Irene Sanna; Filippo Tocco; Maura Marcelli; Andrea Loi; Francesco Corona; Gabriele Mulliri; Alberto Concu; Antonio Crisafulli
Journal:  Eur J Appl Physiol       Date:  2015-10-01       Impact factor: 3.078

Review 3.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

4.  Orthostatic hypotension in a case with multiple sclerosis.

Authors:  R Sakakibara; M Mori; T Fukutake; K Kita; T Hattori
Journal:  Clin Auton Res       Date:  1997-06       Impact factor: 4.435

5.  Rehabilitation challenges in multiple sclerosis.

Authors:  Jack S Burks; George Kim Bigley; Harry Haydon Hill
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

Review 6.  Multiple sclerosis: symptomatic treatment.

Authors:  A J Thompson
Journal:  J Neurol       Date:  1996-08       Impact factor: 4.849

7.  Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.

Authors:  João Carlos Correia de Sa; Laura Airas; Emmanuel Bartholome; Nikolaos Grigoriadis; Heinrich Mattle; Celia Oreja-Guevara; Jonathan O'Riordan; Finn Sellebjerg; Bruno Stankoff; Karl Vass; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  Ther Adv Neurol Disord       Date:  2011-05       Impact factor: 6.570

Review 8.  Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies.

Authors:  Ranan DasGupta; Clare J Fowler
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Paradoxical puborectalis contraction is a feature of constipation in patients with multiple sclerosis.

Authors:  Y W Chia; K P Gill; J S Jameson; A D Forti; M M Henry; M Swash; P J Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

10.  Altered gastrointestinal motility involving autoantibodies in the experimental autoimmune encephalomyelitis model of multiple sclerosis.

Authors:  E T Spear; E A Holt; E J Joyce; M M Haag; S M Mawe; G W Hennig; B Lavoie; A M Applebee; C Teuscher; G M Mawe
Journal:  Neurogastroenterol Motil       Date:  2018-04-11       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.